ADB-FUBINACA
id:
adb-fubinaca-180-8847562
title:
ADB-FUBINACA
text:
ADB-FUBINACA (ADMB-FUBINACA) is a designer drug identified in synthetic cannabis blends in Japan in 2013. In 2018, it was the third-most common synthetic cannabinoid identified in drugs seized by the Drug Enforcement Administration. The (S)-enantiomer of ADB-FUBINACA is described in a 2009 Pfizer patent and has been reported to be a potent agonist of the CB1 receptor and the CB2 receptor with EC50 values of 1.2 nM and 3.5 nM, respectively. ADB-FUBINACA features a carboxamide group at the 3-indaz
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/ADB-FUBINACA
date created:
2013-04-03T03:43:36Z
date modified:
2024-09-05T09:45:49Z
main entity:
{"identifier":"Q15708300","url":"https://www.wikidata.org/entity/Q15708300"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/7/7c/ADB-FUBINACA_structure.png","width":445,"height":483}
fields total:
13
integrity:
16